Lead sponsor
Goldman, Butterwick, Fitzpatrick and Groff
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
2
Active
74
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Not applicable
1
Trials by status
Not yet recruiting
2
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 AgonistFemalenot applicableNot yet recruiting50
Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 AgonistsFemalePh 2Not yet recruiting24